Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Portfolio News / By Karina Tin August 5, 2020
ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update Portfolio News / By Karina Tin August 5, 2020
Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Portfolio News / By Karina Tin July 29, 2020
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Portfolio News / By Karina Tin July 27, 2020
Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering Portfolio News / By Karina Tin July 23, 2020
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Portfolio News / By Karina Tin July 20, 2020
Arcus Biosciences and Gilead Sciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Portfolio News / By Karina Tin July 13, 2020
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock Portfolio News / By Karina Tin July 8, 2020
Arcus Biosciences Appoints Bob Goeltz as Chief Financial Officer Portfolio News / By Karina Tin July 7, 2020
Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor Portfolio News / By Karina Tin June 22, 2020
